Epileptic disorders in Becker and Duchenne muscular dystrophies : a systematic review and meta-analysis
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany..
Dystrophin alterations in the brain have been associated with an increased risk of epilepsy in Becker and Duchenne muscular dystrophies (BMD and DMD). Moreover, an association between the mutation site and the risk of epilepsy is not ruled out. The aim of this systematic review and meta-analysis was to estimate the prevalence of epilepsy in BMD and DMD populations and to establish a possible association between the site of mutation in the dystrophin gene and the risk of epilepsy. Systematic searches of Medline, Scopus, Web of Science, and Cochrane Library were conducted to identify relevant studies published from inception to January 2022. Observational studies of participants with BMD/DMD estimating the prevalence of epilepsy were included. The main outcome was the prevalence of epilepsy, and the secondary outcome was the prevalence ratio considering genotype. A random effects meta-analysis was performed for the prevalence of epilepsy. Eight studies were included in the systematic review and meta-analysis. The prevalence of epilepsy was 7% (95% CI 3-11%) in BMD, 5% (95% CI 2-8%) in DMD, and 5% (95% CI 3-7%) in the overall estimate. No association was observed between mutation site and the prevalence of epilepsy. BMD/DMD is strongly associated with the prevalence of epilepsy, with a higher prevalence in BMD/DMD populations than in the general population, probably owing to alterations in Dp427. The current evidence does not support the hypothesis that Dp140 or Dp71 affect epilepsy risk.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:269 |
---|---|
Enthalten in: |
Journal of neurology - 269(2022), 7 vom: 01. Juli, Seite 3461-3469 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Pascual-Morena, Carlos [VerfasserIn] |
---|
Links: |
---|
Themen: |
Becker muscular dystrophy |
---|
Anmerkungen: |
Date Completed 24.06.2022 Date Revised 24.06.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1007/s00415-022-11040-y |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM337605750 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM337605750 | ||
003 | DE-627 | ||
005 | 20231225234814.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s00415-022-11040-y |2 doi | |
028 | 5 | 2 | |a pubmed24n1125.xml |
035 | |a (DE-627)NLM337605750 | ||
035 | |a (NLM)35229191 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Pascual-Morena, Carlos |e verfasserin |4 aut | |
245 | 1 | 0 | |a Epileptic disorders in Becker and Duchenne muscular dystrophies |b a systematic review and meta-analysis |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 24.06.2022 | ||
500 | |a Date Revised 24.06.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany. | ||
520 | |a Dystrophin alterations in the brain have been associated with an increased risk of epilepsy in Becker and Duchenne muscular dystrophies (BMD and DMD). Moreover, an association between the mutation site and the risk of epilepsy is not ruled out. The aim of this systematic review and meta-analysis was to estimate the prevalence of epilepsy in BMD and DMD populations and to establish a possible association between the site of mutation in the dystrophin gene and the risk of epilepsy. Systematic searches of Medline, Scopus, Web of Science, and Cochrane Library were conducted to identify relevant studies published from inception to January 2022. Observational studies of participants with BMD/DMD estimating the prevalence of epilepsy were included. The main outcome was the prevalence of epilepsy, and the secondary outcome was the prevalence ratio considering genotype. A random effects meta-analysis was performed for the prevalence of epilepsy. Eight studies were included in the systematic review and meta-analysis. The prevalence of epilepsy was 7% (95% CI 3-11%) in BMD, 5% (95% CI 2-8%) in DMD, and 5% (95% CI 3-7%) in the overall estimate. No association was observed between mutation site and the prevalence of epilepsy. BMD/DMD is strongly associated with the prevalence of epilepsy, with a higher prevalence in BMD/DMD populations than in the general population, probably owing to alterations in Dp427. The current evidence does not support the hypothesis that Dp140 or Dp71 affect epilepsy risk | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Meta-Analysis | |
650 | 4 | |a Review | |
650 | 4 | |a Systematic Review | |
650 | 4 | |a Becker muscular dystrophy | |
650 | 4 | |a Duchenne muscular dystrophy | |
650 | 4 | |a Epidemiology | |
650 | 4 | |a Epilepsy | |
650 | 4 | |a Meta-analysis | |
650 | 4 | |a Systematic review | |
650 | 7 | |a Dystrophin |2 NLM | |
700 | 1 | |a Martínez-Vizcaíno, Vicente |e verfasserin |4 aut | |
700 | 1 | |a Saz-Lara, Alicia |e verfasserin |4 aut | |
700 | 1 | |a López-Gil, José Francisco |e verfasserin |4 aut | |
700 | 1 | |a Fernández-Bravo-Rodrigo, Jaime |e verfasserin |4 aut | |
700 | 1 | |a Cavero-Redondo, Iván |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of neurology |d 1974 |g 269(2022), 7 vom: 01. Juli, Seite 3461-3469 |w (DE-627)NLM000508543 |x 1432-1459 |7 nnns |
773 | 1 | 8 | |g volume:269 |g year:2022 |g number:7 |g day:01 |g month:07 |g pages:3461-3469 |
856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00415-022-11040-y |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 269 |j 2022 |e 7 |b 01 |c 07 |h 3461-3469 |